Reactive gliosis is a hallmark of disease-, trauma-, and chemical-induced damage to the CNS. This response is characterized by activation of microglia and astrocytes at sites of damage. Signaling pathways associated with the induction of gliosis remain elusive, but recent evidence implicates the Janus kinase (JAK)-signal transducer and activator of transcription-3 (STAT3) pathway. This pathway is a down-stream effector of cytokines linked to injury-induced astroglial activation and subsequent expression of GFAP, a cellular response that appears to require STAT3 phosphorylation. Here, we seek to further characterize gliosis by elucidating ligands involved in STAT3 phosphorylation and the induction of GFAP. Two injury models were employed. First we administered, in vivo, saline or the dopaminergic neurotoxin, 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP, 12.5mg/kg, sc). 12 hours post-treatment, coronal slices of striatum were examined for STAT3 phosphorylation and cytokine production. pSTAT3 was present in MPTP treated animals while absent in controls. Messenger RNA for gp130 cytokines [leukemia inhibitory factor (LIF) and oncostatin M (OSM)] as well as a glial-derived chemokine (CCL-2/MCP-1) was induced in MPTP treated animals. Striatal slices were then incubated in oxygenated buffer. Within 45 minutes, control striata also expressed p-STAT3 indicating that STAT3 activation can result from slice injury. To confirm the induction of pSTAT3 in vivo, stab wounds were made in striata of mice. GFAP was induced 48 hours after stab and this effect was preceded by pSTAT3 expression. In addition, mRNA for LIF, OSM, and MCP-1 was induced by 24 hours. Since these three ligands were upregulated in both damage models, they were incubated 45 minutes with untreated slices and slices were then assayed for pSTAT3. LIF and OSM promoted glial activation as evidenced by increased pSTAT3 and GFAP protein whereas CCL-2 inhibited gliosis. Together, these data suggest that glial chemokines and gp130 cytokines mediate/modulate reactive gliosis and that pSTAT3 is an early event in glial activation in both neurotoxic and mechanical injury.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.